Introduction
Parkinson’s disease, tremors
ESSENTIAL TREMOR
Patients living with postural and kinetic hand tremors struggle with key activities of daily living such as eating, drinking, and writing [Pharmacological treatments are the primary therapy option for management of ET; however, they are often either ineffective, contraindicated, or associated with side effects that lead to discontinuation for most patients [Given the challenge faced by ET patients and the limited effectiveness and high burden/risk of current treatment options, there is an increasing demand for novel, non-invasive, non-pharmaceutical therapy alternatives. Transcutaneous afferent patterned stimulation (TAPS) is a wrist-worn, non-invasive neuromodulation therapy that delivers individually calibrated stimulation to reduce postural and kinetic tremors. TAPS devices were authorized by the U.S. Food and Drug Administration (DEN170028) for the treatment of essential tremor symptoms, recent label expansion includes both ET and postural and kinetic hand tremors in Parkinson’s disease [While previous studies have demonstrated the effectiveness and safety of TAPS in open-label and sham-controlled studies [